Thiard News@F4F

@newsen.bsky.social

2 weeks ago

ADC Therapeutics Unveils New Employee Inducement Grant to Strengthen Talent Pool ADC Therapeutics announced a new employee inducement grant, issuing stock options to enhance motivation and support performance excellence.

ADC Therapeutics Unveils New Employee Inducement Grant to Strengthen Talent Pool #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

1 month ago

ADC Therapeutics Announces 2025 Financial Outcomes and Future Directions in ADCT Operations ADC Therapeutics reveals its financial and operational outlook for 2025, highlighting new drug trials and strategic partnerships aimed at enhancing revenue and treatment solutions.

ADC Therapeutics Announces 2025 Financial Outcomes and Future Directions in ADCT Operations #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #DLBCL

Thiard News@F4F

@newsen.bsky.social

1 month ago

ADC Therapeutics Offers Stock Options to New Employees Under Inducement Plan ADC Therapeutics has announced stock option grants to new hires as part of its induction strategy, aimed to enhance employee motivation and retention.

ADC Therapeutics Offers Stock Options to New Employees Under Inducement Plan #stock_options #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne

Thiard News@F4F

@newsen.bsky.social

1 month ago

ADC Therapeutics Enhances Flexibility with Amended Royalty Financing Agreement ADC Therapeutics announces a revised financing agreement with HealthCare Royalty to boost strategic flexibility and support growth for ZYNLONTA.

ADC Therapeutics Enhances Flexibility with Amended Royalty Financing Agreement #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #HealthCare_Royalty

Thiard News@F4F

@newsen.bsky.social

2 months ago

ADC Therapeutics Announces Grants for New Employees Under Inducement Plan ADC Therapeutics has granted share options to new employees as part of its Inducement Plan, aiming to enhance performance and commitment within the company.

ADC Therapeutics Announces Grants for New Employees Under Inducement Plan #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

2 months ago

Pomerantz Law Firm Launches Investigation into ADC Therapeutics SA for Possible Securities Fraud Pomerantz LLP is investigating ADC Therapeutics SA on behalf of investors. The probe focuses on potential securities fraud and unlawful business practices linked to the company.

Pomerantz Law Firm Launches Investigation into ADC Therapeutics SA for Possible Securities Fraud #United_States #New_York #Pomerantz_LLP #ADC_Therapeutics #ZYNLONTA

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pomerantz Law Firm Launches Investigation into ADC Therapeutics for Possible Fraudulent Activities Pomerantz LLP is probing potential securities fraud involving ADC Therapeutics, urging investors to join a class action. Recent data shows concerns over patient safety.

Pomerantz Law Firm Launches Investigation into ADC Therapeutics for Possible Fraudulent Activities #USA #New_York #Securities_Fraud #Pomerantz_LLP #ADC_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 months ago

ADC Therapeutics Releases Preliminary Revenue Estimates for 2025 and Clinical Updates Discover ADC Therapeutics' preliminary performance metrics for 2025, including significant developments and future clinical trials related to ZYNLONTA.

ADC Therapeutics Releases Preliminary Revenue Estimates for 2025 and Clinical Updates #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #LOTIS_trials

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pomerantz Law Firm Launches Investigation into ADC Therapeutics for Securities Fraud Allegations Pomerantz LLP has initiated an investigation concerning ADC Therapeutics SA in light of a recent press release that raised concerns among investors over potential securities fraud.

Pomerantz Law Firm Launches Investigation into ADC Therapeutics for Securities Fraud Allegations #USA #New_York #Pomerantz #SEC_Investigation #ADC_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 months ago

ADC Therapeutics to Showcase Innovations at J.P. Morgan Healthcare Conference 2026 ADC Therapeutics will present at the upcoming J.P. Morgan Healthcare Conference 2026, highlighting advancements in antibody-drug conjugates and patient treatment.

ADC Therapeutics to Showcase Innovations at J.P. Morgan Healthcare Conference 2026 #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

3 months ago

ADC Therapeutics Awards Grant to New Employee Supporting Growth Initiatives ADC Therapeutics has announced a new employee inducement grant allowing for the purchase of 6,000 common shares, enhancing their strategic workforce.

ADC Therapeutics Awards Grant to New Employee Supporting Growth Initiatives #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pomerantz Law Firm Probes Securities Fraud Claims Against ADC Therapeutics SA Investors of ADC Therapeutics SA may face potential securities fraud issues as Pomerantz Law Firm initiates a probe into the company's practices. Contact them for details.

Pomerantz Law Firm Probes Securities Fraud Claims Against ADC Therapeutics SA #United_States #New_York #Securities_Fraud #Pomerantz_LLP #ADC_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 months ago

The Shift Towards Platform Technologies in Oncology: Why 60% of Pharma Pipelines Are Changing As smart investments sharply shift towards platform-based therapies in oncology, discover how this trend is redefining pharmaceutical pipelines and clinical advancements.

The Shift Towards Platform Technologies in Oncology: Why 60% of Pharma Pipelines Are Changing #USA #Vancouver #ADC_Therapeutics #GT_Biopharma #Sutro_Biopharma

Thiard News@F4F

@newsen.bsky.social

4 months ago

Pomerantz Law Firm Launches Investigation into ADC Therapeutics for Investors' Claims Pomerantz LLP is investigating allegations of potential securities fraud involving ADC Therapeutics, seeking investors to join the inquiry following troubling clinical trial results.

Pomerantz Law Firm Launches Investigation into ADC Therapeutics for Investors' Claims #USA #New_York #Pomerantz_LLP #ADC_Therapeutics #ADCT

Thiard News@F4F

@newsen.bsky.social

4 months ago

ADC Therapeutics Expands Workforce with Inducement Grants to New Hires ADC Therapeutics has announced the granting of stock options to several new employees as part of their induction plan. This strategic move aims to enhance motivation and retention.

ADC Therapeutics Expands Workforce with Inducement Grants to New Hires #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

5 months ago

ADC Therapeutics Provides Financial and Operational Insights for Q3 2025 ADC Therapeutics has released its financial results for Q3 2025, showcasing progress in clinical trials and increased funding in operations.

ADC Therapeutics Provides Financial and Operational Insights for Q3 2025 #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #LOTIS_trials

Thiard News@F4F

@newsen.bsky.social

5 months ago

ADC Therapeutics to Showcase Innovative Developments at November Investor Conferences ADC Therapeutics will participate in three investor conferences this November, highlighting advancements in antibody drug conjugates and future prospects.

ADC Therapeutics to Showcase Innovative Developments at November Investor Conferences #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

6 months ago

ADC Therapeutics Secures $60 Million Through Private Placement Financing for Growth ADC Therapeutics recently announced a $60 million private investment in public equity to strengthen its balance sheet and fund the expansion of ZYNLONTA.

ADC Therapeutics Secures $60 Million Through Private Placement Financing for Growth #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #Private_Placement

Thiard News@F4F

@newsen.bsky.social

6 months ago

ADC Therapeutics Introduces Inducement Grants for New Employees to Boost Engagement and Performance ADC Therapeutics has launched a new inducement plan, granting stock options to four new hires. This initiative aims to enhance employee motivation and company success.

ADC Therapeutics Introduces Inducement Grants for New Employees to Boost Engagement and Performance #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

7 months ago

ADC Therapeutics Introduces Grant Program for New Employees to Enhance Engagement and Performance ADC Therapeutics has launched a new inducement grant program for employees to boost performance and commitment. This initiative highlights their strategic growth ambitions in the competitive market.

ADC Therapeutics Introduces Grant Program for New Employees to Enhance Engagement and Performance #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

7 months ago

ADC Therapeutics Announces Participation at 2025 Cantor Global Healthcare Conference ADC Therapeutics is set to showcase its advancements at the upcoming 2025 Cantor Global Healthcare Conference, led by CEO Ameet Mallik. Learn more about their innovative approaches to cancer treatment.

ADC Therapeutics Announces Participation at 2025 Cantor Global Healthcare Conference #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

8 months ago

ADC Therapeutics Reports Impressive Results and Financial Updates for Q2 2025 ADC Therapeutics has released its Q2 2025 financial results, showcasing significant operational advancements and strong clinical data for its product ZYNLONTA®.

ADC Therapeutics Reports Impressive Results and Financial Updates for Q2 2025 #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #glofitamab

Thiard News@F4F

@newsen.bsky.social

8 months ago

ADC Therapeutics Expands Workforce with New Inducement Grants for Employees In an effort to attract top-level talent, ADC Therapeutics has granted stock options to new employees, reinforcing its commitment to growth and innovation.

ADC Therapeutics Expands Workforce with New Inducement Grants for Employees #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #antibody_drug_conjugates

Thiard News@F4F

@newsen.bsky.social

9 months ago

ADC Therapeutics Expands Team with New Employee Stock Incentive Grant ADC Therapeutics has announced a grant of stock options to a new employee, aimed at boosting motivation and performance within the company.

ADC Therapeutics Expands Team with New Employee Stock Incentive Grant #stock_options #ADC_Therapeutics #ZYNLONTA

Thiard News@F4F

@newsen.bsky.social

10 months ago

ADC Therapeutics Reveals Promising ZYNLONTA® Data for Marginal Zone Lymphoma at ICML 2025 ADC Therapeutics presented significant findings on ZYNLONTA® for relapsed/refractory marginal zone lymphoma at the ICML, showcasing a high response rate and prolonged effectiveness.

ADC Therapeutics Reveals Promising ZYNLONTA® Data for Marginal Zone Lymphoma at ICML 2025 #Switzerland #ADC_Therapeutics #Lausanne #ZYNLONTA® #Marginal_Zone_Lymphoma

Thiard News@F4F

@newsen.bsky.social

10 months ago

ADC Therapeutics Secures $100 Million in Private Placement, Paving the Way for Future Growth ADC Therapeutics has successfully completed a $100 million private placement, extending its financial runway into 2028 while focusing on its key product ZYNLONTA.

ADC Therapeutics Secures $100 Million in Private Placement, Paving the Way for Future Growth #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #Private_Placement

Thiard News@F4F

@newsen.bsky.social

10 months ago

ADC Therapeutics Incentivizes New Employees with Stock Options Grants ADC Therapeutics has announced the granting of stock options to new employees, aiming to boost motivation and performance under its Inducement Plan.

ADC Therapeutics Incentivizes New Employees with Stock Options Grants #stock_options #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne

Thiard News@F4F

@newsen.bsky.social

11 months ago

ADC Therapeutics Set to Showcase Innovations at Notable Investor Conferences ADC Therapeutics announces its participation in two prestigious investor conferences featuring insights from CEO Ameet Mallik regarding advancements in ADC technology.

ADC Therapeutics Set to Showcase Innovations at Notable Investor Conferences #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #Ameet_Mallik

Thiard News@F4F

@newsen.bsky.social

11 months ago

ADC Therapeutics Releases Promising Q1 2025 Financial Results and LOTIS-7 Clinical Updates ADC Therapeutics showcases strong Q1 2025 financial results and highlights publication of LOTIS-7 clinical trial data, suggesting a bright future.

ADC Therapeutics Releases Promising Q1 2025 Financial Results and LOTIS-7 Clinical Updates #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #LOTIS-7

Thiard News@F4F

@newsen.bsky.social

11 months ago

ADC Therapeutics Unveils Promising Preclinical Results at AACR 2025 Annual Meeting ADC Therapeutics presents significant preclinical findings at AACR 2025, revealing the potential of their exatecan-based ADCs in treating various cancers.

ADC Therapeutics Unveils Promising Preclinical Results at AACR 2025 Annual Meeting #Cancer_Research #Switzerland #ADC_Therapeutics #Lausanne #ADCT-242